Expression of neurotensin and its receptors in pituitary adenomas

Journal of Neuroendocrinology

Volumn 20, Issue 9, 2008, Pages 1052-1057

  Giorgi, R R ^a   Chile, T ^a   Bello, A R ^b,c   Reyes, R ^b,c   Fortes, M A H Z ^a   Machado, M C ^a   Cescato, V A ^a   Musolino, N R ^a   Bronstein, M D ^a   Giannella neto, D ^a   Corrêa giannella, Maria Lúcia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c Madrid Spain   (Spain)

Author keywords

Neurotensin; Neurotensin receptors; Pituitary adenomas; RT qPCR

Indexed keywords

CORTICOTROPIN; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; MESSENGER RNA; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR 1; NEUROTENSIN RECEPTOR 2; NEUROTENSIN RECEPTOR 3; PROLACTIN;

ACTH SECRETING ADENOMA; ACTH SECRETING CELL; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GROWTH HORMONE SECRETING ADENOMA; GROWTH HORMONE SECRETING CELL; HUMAN; HUMAN TISSUE; HYPOPHYSECTOMY; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; NONFUNCTIONING PITUITARY ADENOMA; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; PROLACTINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THERAPY RESISTANCE;

ADENOMA; ADULT; AGED; AUTOCRINE COMMUNICATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEUROTENSIN; PARACRINE COMMUNICATION; PITUITARY NEOPLASMS; RECEPTORS, NEUROTENSIN; RNA, MESSENGER; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 49449103361     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2008.01761.x     Document Type: Article

References (34)

1. Greenman Y, Melmed S. Diagnosis and management of nonfunctioning pituitary tumors. Annu Rev Med 1996; 47: 95-106.
2. Moreno CS, Evans CO, Zhan X, Okor M, Desiderio DM, Oyesiku NM. Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses. Cancer Res 2005; 65: 10214-10222.
3. Evans CO, Young AN, Brown MR, Brat DJ, Parks JS, Neish AS, Oyesiku NM. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 2001; 86: 3097-3107.
4. Morris DG, Musat M, Czirják S, Hanzély Z, Lillington DM, Korbonits M, Grossman AB. Differential gene expression in pituitary adenomas by oligonucleotide array analysis. Eur J Endocrinol 2005; 153: 143-151.
5. Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Agi CU, Redpath GT, Fang Z, Leung GK, Lopes MB, Laws ER. Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 2007; 170: 356-365.
6. Hu J, Song H, Wang X, Shen Y, Chen F, Liu Y, Li S, Wang Y, Shou X, Zhang Y, Hu R. Gene expression profiling in human null cell pituitary adenoma tissue. Pituitary 2007; 10: 47-52.
7. Giorgi RR, Correa-Giannella ML, Casarini AP, Machado MC, Bronstein MD, Cescato VA, Giannella-Neto D. Metallothionein isoform 3 gene is differentially expressed in corticotropin-producing pituitary adenomas. Neuroendocrinology 2005; 82: 208-214.
8. Carraway R, Leeman SE. The isolation of a new hypotensive peptide, neurotensin from bovine hypothalami. J Biol Chem 1973; 248: 6854-6861.
9. Rostène WH, Alexander MJ. Neurotensin and neuroendocrine regulation. Front Neuroendocrinol 1997; 18: 115-173.
10. Zhao D, Pothoulakis C. Effects o NT on gastrointestinal motility and secretion, and role in intestinal inflammation. Peptides 2006; 27: 2434-2444.
11. Vincent JP, Mazella J, Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol Sci 1999; 20: 302-309.
12. Carraway RE, Plona AM. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides 2006; 27: 2445-2460.
13. Evers BM. Neurotensin and growth of normal and neoplastic tissues. Peptides 2006; 27: 2424-2433.
14. Gendron L, Perron A, Payet MD, Gallo-Payet N, Sarret P, Beaudet A. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2. Mol Pharmacol 2004; 66: 1421-1430.
15. Mazella J, Vincent JP. Functional roles of the NTS2 and NTS3 receptors. Peptides 2006; 27: 2469-2475.
16. Elek J, Pinzon W, Park KH, Narayanan R. Relevant genomics of neurotensin receptor in cancer. Anticancer Res 2000; 20: 53-58.
17. Wang L, Friess H, Zhu Z, Graber H, Zimmermann A, Korc M, Reubi JC, Büchler MW. Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. Clin Cancer Res 2000; 6: 566-571.
18. Martin S, Navarro V, Vincent JP, Mazella J. Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology 2002; 123: 1135-1143.
19. Reyes R, Valladares F, Díaz-Flores L, Feria L, Alonso R, Tramu G, Bello AR. Immunohistochemical localization of hormones and peptides in the human pituitary cells in a case of hypercortisolism by ACTH secreting microadenoma. Histol Histopathol 2007; 22: 709-717.
20. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(--△△CT). Methods 2001; 25: 402-408.
22. Studler JM, Kitabgi P, Tramu G, Herve D, Glowinski J, Tassin JP. Extensive co-localization of neurotensin with dopamine in rat meso-cortico-frontal dopaminergic neurons. Neuropeptides 1988; 11: 95-100.
23. Tramu G, Pillez A, Leonardelli J. An efficient method of antibody elution for the successive or simultaneous localization of two antigens by immunocytochemistry. J Histochem Cytochem 1978; 26: 322-324.
24. Vijayan E, Carraway R, Leeman SE, McCann SM. Physiological significance of neurotensin in pituitary glycoprotein hormone release as revealed by in vivo and in vitro studies with neurotensin. Neuroendocrinology 1994; 60: 157-164.
25. Bello AR, Hernández G, González M, Reyes R, Negrín I, Marrero A, Sánchez-Criado JE, Tramu G, Alonso R. Immunoreactive neurotensin in gonadotrophs and thyrotrophs is regulated by sex steroid hormones in the female rat. J Neuroendocrinol 1999; 11: 785-794.
26. Bello AR, Reyes R, Hernández G, Negrín I, González M, Tramu G, Alonso R. Developmental expression of neurotensin in thyrotrophs and gonadotrophs of male and female rats. Neuroendocrinology 2004; 79: 90-99.
27. Reubi JC, Waser B, Schaer JC, Laissue JA. Neurotensin receptors in human neoplasms: High incidence in Ewing's sarcomas. Int J Cancer 1999; 19: 213-218.
28. Dal Farra C, Sarret P, Navarro V, Botto JM, Mazella J, Vincent JP. Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines. Int J Cancer 2001; 15: 503-509.
29. Martin S, Vincent JP, Mazella J. Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J Neurosci 2003; 23: 1198-1205.
30. Evers BM, Zhou Z, Dohlen V, Rajaraman S, Thompson JC, Townsend CM Jr. Fetal and neoplastic expression of the neurotensin gene in the human colon. Ann Surg 1996; 223: 464-470.
31. SouazéF, Dupouy S, Viardot-Foucault V, Bruyneel E, Attoub S, Gespach C, Gompel A, Forgez P. Expression of neurotensin and NT1 receptor in human breast cancer: A potential role in tumor progression. Cancer Res 2006; 15: 6243-6249.
32. Evers BM. Endocrine gene neurotensin: Molecular mechanisms and a model of intestinal differentiation. World J Surg 2002; 26: 799-805.
33. de Lange R, Dimoudis N, Weidle UH. Identification of genes associated with enhanced metastasis of a large cell lung carcinoma cell line. Anticancer Res 2003; 23: 187-194.
34. SomaïS, Gompel A, Rostène W, Forgez P. Neurotensin counteracts apoptosis in breast cancer cells. Biochem Biophys Res Commun 2002; 12: 482-488.